Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10172398 | 0.84 | CNR1 (0.33) | CNR1 | |
| SCHEMBL17539179 | 0.81 | CA3 (0.38) | CA3CA5ACA5B | |
| SCHEMBL23073275 | 0.81 | CNR1 (0.33) | CNR1CA3CA5ACA5B | |
| SCHEMBL18530841 | 0.79 | KDM4C (0.40) | CNR1 | |
| SCHEMBL2845918 | 0.77 | POLB (0.42) | CNR1CA3CA5ACA5B | |
| SCHEMBL10172400 | 0.75 | POLB (0.35) | CNR1CA3CA5ACA5B | |
| SCHEMBL18874574 | 0.75 | RIPK1 (0.34) | — | |
| SCHEMBL18530842 | 0.74 | MEN1 (0.41) | CA3CA5ACA5B | |
| SCHEMBL26347887 | 0.71 | EPHX2 (0.38) | — | |
| SCHEMBL13156166 | 0.71 | GAA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9095623-B2 | Terminally-functionalized conjugates and uses thereof | SMARTCELLS, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20140121159-A1 | TERMINALLY–FUNCTIONALIZED CONJUGATES AND USES THEREOF | SMARTCELLS, INC. (US) | 2014-05-01 | — | — | US | disclosed |
| US-8623345-B2 | Terminally-functionalized conjugates and uses thereof | Smartcells (US) | 2014-01-07 | — | — | US | disclosed |
| US-20120014908-A1 | TERMINALLY-FUNCTIONALIZED CONJUGATES AND USES THEREOF | SMARTCELLS, INC. | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121159-A1 | TERMINALLY–FUNCTIONALIZED CONJUGATES AND USES THEREOF | NPY1R, NTSR1, GRPR | CNR1 571/4885CA3 1261/4885CA5A 322/4885 |
| US-20120014908-A1 | TERMINALLY-FUNCTIONALIZED CONJUGATES AND USES THEREOF | NPY1R, NTSR1, GRPR | CNR1 579/4885CA3 1079/4885CA5A 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.